...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

Here's some more background about the Resverlogix pulmonary arterial hypertension (PAH) program from a prior post. And here's the prior news release on the trial funding.

BearDownAZ

Share
New Message
Please login to post a reply